Denmark Austria temporarily suspend AstraZeneca vaccine over blood clot reports

Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions and a death.

The Danish Health Authority said it would temporarily stop the vaccination as a precaution “after reports of severe cases of blood clots in people who have been vaccinated with the COVID-19 vaccine from AstraZeneca.”

“Against this background, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. At present, it cannot be concluded whether there is a link between the vaccine and the blood clots,” the health authority said in a statement.

The health authority has not specified the number of cases reported.

AstraZeneca COVID vaccine

The decision to put the vaccine on hold in Denmark and Austria will be a great setback to the already slow European vaccination campaign.

Austria, too, has announced a temporary stoppage of the vaccine beginning of this week following one person’s death and the illness of another after they got inoculated with the vaccine. Austria suspended the use of a particular batch of the drug because a woman died ten days after taking it. Estonia, Latvia, Lithuania and Luxemburg have also stopped using the batch.

Søren Brostrøm, director of the National Board of Health in Denmark, made it clear that the two-week suspension was a precaution and investigations were on.

The news has sent the shares of AstraZeneca down by 2.4% on the London Stock Exchange on Thursday.

An AstraZeneca spokesperson said that the company was aware of the temporary suspension of the vaccine by the Danish Health Authority and it is currently investigating potential adverse effects related to the vaccine.

The University of Oxford refused to comment.

The decision to put the vaccine on hold in Denmark and Austria will be a great setback to the already slow European vaccination campaign. The European Medicine Agency or EMA said its safety committee was reviewing the Austrian case, but made clear that “there is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine.”

The number of “thromboembolic events in vaccinated people is no higher than that seen in the general population”, it added.

Overall, 22 cases of thromboembolic events have been reported among the three million people vaccinated with the AstraZeneca vaccine in the European Economic Area, according to a BBC report.

Subscribe to the nation’s fastest-growing business magazine to get the latest COVID-19 vaccine news and updates.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Monte dei Paschi performance below par in EU banks stress test

Monte dei Paschi performance below par in EU banks stress test

The depletion of capital at each bank under the test’s harshest scenario will be closely scrutinised, and could potentially lead to hostile takeovers
1 day ago
Nokia to launch T20 tablet with 10.36 inch display

Nokia to launch T20 tablet with 10.36 inch display

The Nokia T20 will sport a 10.36-inch display and will have 4 GB RAM along with 64 gigs of native storage.
3 days ago
Ford sees surprise Q2 profit despite chip shortage and manufacturing hassles

Ford sees surprise Q2 profit despite chip shortage and manufacturing hassles

“The business is ‘spring loaded’ for a rebound when semiconductor supplies stabilize and more closely match demand.”
3 days ago
Audi A6 E-tron Production Launch in 2023

Audi A6 E-tron Production Launch in 2023

Audi has confirmed that there will be multiple variants of the etron, including “basic versions optimized for minimum consumption and maximum range.
4 days ago
Royal Dutch Shell buyback lifts investor sentiment

Royal Dutch Shell buyback lifts investor sentiment

Royal Dutch Shell commences share buybacks before the end of this year while reducing its first quarter dividend to 16 cents per share, a 66% cut.
4 days ago
Citizens Financial to acquire Investors Bancorp in $3.5 billion NYC push

Citizens Financial to acquire Investors Bancorp in $3.5 billion NYC push

Citizens Financial Group, Inc. and Investors Bancorp announced today that they have entered into a definitive agreement and plan of merger in a cash-and-stock deal worth $3.5 billi
5 days ago